Ages: 16-75
Gender: All
Study Description:
This study is testing an investigational injectable medication compared to its matching placebo for the treatment of Ulcerative Colitis. Participants will receive the study medication or placebo intravenously for 12 weeks, followed by subcutaneous injections every 2 to 4 weeks for a treatment period of 1 year. Additional procedures include physical examinations, vital signs, laboratory tests, an endoscopy and a biopsy. Total participation will last approximately 1 year and 4 months and would include 16 clinic visits throughout the study. Eligibility for the study will be determined by the study doctor following one in-person screening visit to the clinic. Trial-related procedures and study medication will be provided at no cost.

Qualifications:
- Must have had UC for 3 months or longer
- Have experienced a flare up in the last 3 months

Highest DQs:
Medication hasn't been effective or had intolerable side effects
Cannot have other inflammatory bowel diseases

PROOF REQUIRED

Mailer Access: Key https://www.affiliateaccesskey.com/m-dzkm-s96-408d87cf2deb179a3245a40c65bcb70d
Optout Link: https://www.twonailhall.com/o-dzkm-s96-ea5092831cdcd7d959f9e4a23a5483dd